Newsfeeds - Spark Newswire

1 minute read

FDA
News

Coherus Announces BLA Filing For Lucentis (ranibizumab) Biosimilar Candidate Accepted By FDA For Review

Today, 1:35 PM

Coherus BioSciences, Inc. (("Coherus", NASDAQ:CHRS) today announced the United States Food and Drug Administration (FDA) has accepted for review the 351(k) Biologics License Application (BLA) for CHS-201,

CHRS

1 minute read

Junshi Biosciences, Coherus Share Toripalimab Survival Data In Esophageal Cancer

By Vandana Singh

Today, 1:35 PM

Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ: CHRS) announced interim results from the Phase 3 JUPITER-06 trial.

CHRS

2 minute read

FDA
News

Coherus, Junshi Biosciences Announce Results From Phase 3 Study Of Toripalimab Published In September Issue Of Nature Medicine

By Benzinga Newsdesk

Today, 1:35 PM

Coherus BioSciences, Inc. (("Coherus", NASDAQ:CHRS) and Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) today announced publication of a cover article in the

CHRS

6 minute read

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout

By Shanthi Rexaline

Today, 1:35 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13)

ABT

4 minute read

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs

By Shanthi Rexaline

Today, 1:35 PM

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.

ALRN

4 minute read

38 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 1:35 PM

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial results for the three months ended June 30th , 2021 and issued a business update.

AEYE

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 1:35 PM

CHRS

3 minute read

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

By Shanthi Rexaline

Today, 1:35 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18)

ABBV

5 minute read

News

Coherus and Junshi Biosciences Late Yesterday Announcd Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

By Benzinga Newsdesk

Today, 1:35 PM

Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. ((&ldquo, Coherus&rdquo, , NASDAQ:CHRS), today announced positive interim

CHRS

1 minute read

See Why Coherus Stock Is Rising After Toripalimab Combination Trial In Lung Cancer

By Vandana Singh

Today, 1:35 PM

Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ:CHRS) announced positive interim results from CHOICE-01 Phase 3 trial evaluating toripalimab plus chemotherapy…